Loading
Latest filing published 04 Nov 2008 for RxElite, Inc., €79k.
No signal scores available.
This profile gathers the share dealings of Earl Sullivan in RxElite, Inc. In total, 2 filings cover trades dated from 8 August 2008 to 24 September 2008.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 4 November 2008, reports a share grant of €79k in RxElite, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations